{"title":"The Potency of Beligo Seeds (Benincasa hispida (Thunb.) Cogn.) as Antihyperlipidemic in L-NAME-induced Hyperlipidemic Rats","authors":"Nur Alim","doi":"10.55262/fabadeczacilik.1200880","DOIUrl":null,"url":null,"abstract":"Beligo or Bligo is the name of Benincasa hispida (Thunb.) Cogn. in Indonesian, is empirically used in the treatment of cholesterol and hypertension. The part of the plant used is the seed. This have a look at aimed to determine the antihyperlipidemic activity of beligo seeds in L-NAME-induced hyperlipidemic rats. Male albino rats (n= 25) were divided into 5 groups: Sod. CMC 1%, plant extract (100 mg/kg, 200 mg/kg, 300 mg/kg body weight), and Simvastatin were induced by L-NAME 40 mg/kg BW for 4 weeks. Measurement of lipid profile levels consisting of TC, HDL, LDL, TG, and VLDL, using a human analyzer (Thermo Scientific Indico®). L-NAME was shown to significantly (p","PeriodicalId":36004,"journal":{"name":"Fabad Journal of Pharmaceutical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fabad Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55262/fabadeczacilik.1200880","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Beligo or Bligo is the name of Benincasa hispida (Thunb.) Cogn. in Indonesian, is empirically used in the treatment of cholesterol and hypertension. The part of the plant used is the seed. This have a look at aimed to determine the antihyperlipidemic activity of beligo seeds in L-NAME-induced hyperlipidemic rats. Male albino rats (n= 25) were divided into 5 groups: Sod. CMC 1%, plant extract (100 mg/kg, 200 mg/kg, 300 mg/kg body weight), and Simvastatin were induced by L-NAME 40 mg/kg BW for 4 weeks. Measurement of lipid profile levels consisting of TC, HDL, LDL, TG, and VLDL, using a human analyzer (Thermo Scientific Indico®). L-NAME was shown to significantly (p
期刊介绍：
The FABAD Journal of Pharmaceutical Sciences is published triannually by the Society of Pharmaceutical Sciences of Ankara (FABAD). All expressions of opinion and statements of supposed facts appearing in articles and/or advertisiments carried in this journal are published on the responsibility of the author and/or advertiser, anda re not to be regarded those of the Society of Pharmaceutical Sciences of Ankara. The manuscript submitted to the Journal has the requirement of not being published previously and has not been submitted elsewhere. Manuscripts should be prepared in accordance with the requirements specified as given in detail in the section of “Information for Authors”. The submission of the manuscript to the Journal is not a condition for acceptance; articles are accepted or rejected on merit alone. All rights reserved.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
